Ocular Surface Disease: From Bench to Bedside

Ocular Surface Disease (OSD) refers to a group of disorders affecting the outermost layer of the eye, including the cornea and conjunctiva. This encompasses a wide range of conditions, such as dry eye syndrome, blepharitis, and ocular allergies. OSD can lead to symptoms such as irritation, redness, tearing, and blurred vision, significantly impacting the patient's quality of life. Advancements in understanding the pathophysiology of OSD have led to developments in diagnostic and treatment modalities, bridging the gap from laboratory research to clinical practice. Diagnostic tools such as tear film osmolarity measurement, meibomian gland imaging, and inflammatory biomarker analysis aid in accurate assessment and personalized management strategies. Treatment approaches for OSD vary depending on the underlying cause and severity of the condition. This may include artificial tear supplementation, anti-inflammatory medications, lid hygiene practices, and in severe cases, surgical interventions such as punctal plugs or amniotic membrane transplantation.

  • Pathophysiology and Biomarkers
  • Diagnostic Innovations
  • Therapeutic Strategies
  • Translational Research and Clinical Implementation

    Related Conference of Ocular Surface Disease: From Bench to Bedside

    October 15-16, 2026

    8th International Conference on Optometry

    Paris, France
    December 03-04, 2026

    9th International Eye and Vision Congress

    Madrid, Spain
    March 25-26, 2027

    41st European Ophthalmology Congress

    Paris, France
    April 28-29, 2027

    4th International Conference on Ophthalmology

    Paris, France

    Ocular Surface Disease: From Bench to Bedside Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in